Switzerland · 
What does BB Biotech Ventures invest in?
BB Biotech Ventures invests most often at Series C and Series B (54% of the rounds on record), in sectors such as Energy Storage and Food And Beverage.
BB Biotech Ventures highlights
- 01
31 rounds on record
- 02
Mostly Series C and Series B: 54% of its rounds
- 03
3 exits from the portfolio
What they do
Diese neue Domain wurde im Kundenauftrag registriert.From their own website
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Stages
- BuyoutGrowthSeedSeries A
- Sectors
- Energy StorageFood And Beverage
- Based in
- Switzerland
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first31 appearances
- 2018
1 round
- Feb
- 2017
1 round
- Jan
- 2016
1 round
- Dec
- 2015
1 round
- Jan
- 2014
2 rounds
- Sept
- Apr
- 2013
3 rounds
- Oct
- Apr
- Apr
- 2012
2 rounds
- Feb
- Jan
- 2011
4 rounds
- Dec
- Sept
- Jul
- Jul
- 2010
1 round
- Feb
- 2009
5 rounds
- Dec
- Nov
- Aug
- Apr
- Apr
- 2008
3 rounds
- Nov
- Sept
- Feb
- 2007
4 rounds
- Aug
- Aug
- Aug
- Apr
- 2006
1 round
- Jan
- 2005
1 round
- Dec
- 2003
1 round
- Nov
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed3 in all
Auxilium PharmaceuticalsBought by Endo Health Solutions$2.6BOct 2014
Optimer PharmaceuticalsBought by Cubist Pharmaceuticals$535MJul 2013
Auxilium PharmaceuticalsListedUndisclosedDec 2007
An exit counts when it came after the firm's first round in the company. From historical deal records.